399 related articles for article (PubMed ID: 25830296)
21. Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.
Wu M; Yu Q; Li Q
Oncotarget; 2016 Dec; 7(50):82074-82084. PubMed ID: 27738338
[TBL] [Abstract][Full Text] [Related]
22. Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride.
Nguyen DD; Marchese M; Cone EB; Paciotti M; Basaria S; Bhojani N; Trinh QD
JAMA Dermatol; 2021 Jan; 157(1):35-42. PubMed ID: 33175100
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.
Mella JM; Perret MC; Manzotti M; Catalano HN; Guyatt G
Arch Dermatol; 2010 Oct; 146(10):1141-50. PubMed ID: 20956649
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia.
Di Loreto C; La Marra F; Mazzon G; Belgrano E; Trombetta C; Cauci S
PLoS One; 2014; 9(6):e100237. PubMed ID: 24959691
[TBL] [Abstract][Full Text] [Related]
25. Dutasteride in Androgenetic Alopecia: An Update.
Arif T; Dorjay K; Adil M; Sami M
Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
[TBL] [Abstract][Full Text] [Related]
26. An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia.
Chiriacò G; Cauci S; Mazzon G; Trombetta C
Andrology; 2016 Mar; 4(2):245-50. PubMed ID: 26763726
[TBL] [Abstract][Full Text] [Related]
27. Finasteride in the treatment of alopecia.
Libecco JF; Bergfeld WF
Expert Opin Pharmacother; 2004 Apr; 5(4):933-40. PubMed ID: 15102575
[TBL] [Abstract][Full Text] [Related]
28. Atypical post-finasteride syndrome: A pharmacological riddle.
Gupta AK; Sharma N; Shukla P
Indian J Pharmacol; 2016; 48(3):316-7. PubMed ID: 27298504
[TBL] [Abstract][Full Text] [Related]
29. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
[TBL] [Abstract][Full Text] [Related]
30. Finasteride adverse effects in subjects with androgenic alopecia: A possible therapeutic approach according to the lateralization process of the brain.
Motofei IG; Rowland DL; Georgescu SR; Tampa M; Baconi D; Stefanescu E; Baleanu BC; Balalau C; Constantin V; Paunica S
J Dermatolog Treat; 2016 Nov; 27(6):495-497. PubMed ID: 27046152
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride.
Gupta AK; Charrette A
J Dermatolog Treat; 2014 Apr; 25(2):156-61. PubMed ID: 23768246
[TBL] [Abstract][Full Text] [Related]
32. Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
Gupta MA; Vujcic B; Gupta AK
Skinmed; 2020; 18(3):146-150. PubMed ID: 32790610
[TBL] [Abstract][Full Text] [Related]
33. [Finasteride adverse effects: An update].
Carreño-Orellana N; Moll-Manzur C; Carrasco-Zuber JE; Álvarez-Véliz S; Berroeta-Mauriziano D; Porras-Kusmanic N
Rev Med Chil; 2016 Dec; 144(12):1584-1590. PubMed ID: 28393993
[TBL] [Abstract][Full Text] [Related]
34. The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.
Said MA; Mehta A
Curr Urol Rep; 2018 Jun; 19(8):65. PubMed ID: 29909472
[TBL] [Abstract][Full Text] [Related]
35. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
Lee S; Lee YB; Choe SJ; Lee WS
Acta Derm Venereol; 2019 Jan; 99(1):12-17. PubMed ID: 30206635
[TBL] [Abstract][Full Text] [Related]
36. Post-finasteride syndrome: a surmountable challenge for clinicians.
Traish AM
Fertil Steril; 2020 Jan; 113(1):21-50. PubMed ID: 32033719
[TBL] [Abstract][Full Text] [Related]
37. Persistent sexual side effects of finasteride: could they be permanent?
Irwig MS
J Sex Med; 2012 Nov; 9(11):2927-32. PubMed ID: 22789024
[TBL] [Abstract][Full Text] [Related]
38. Finasteride for hair loss: a review.
Gupta AK; Venkataraman M; Talukder M; Bamimore MA
J Dermatolog Treat; 2022 Jun; 33(4):1938-1946. PubMed ID: 34291720
[TBL] [Abstract][Full Text] [Related]
39. Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms.
Ganzer CA; Jacobs AR; Iqbal F
Am J Mens Health; 2015 May; 9(3):222-8. PubMed ID: 24928450
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system.
Shin JW; Chung EH; Kim MB; Kim TO; Kim WI; Huh CH
J Dermatol; 2019 Feb; 46(2):139-143. PubMed ID: 30536893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
